Clinical Relevance of Local Renin Angiotensin Systems

Aliskiren Reduces Myocardial Ischemia–Reperfusion Injury by a Bradykinin B 2 Receptor– and Angiotensin AT 2 Receptor–Mediated Mechanism

(2014) Suang Suang Koid et al.   HYPERTENSION

Update on the Angiotensin Converting Enzyme 2-Angiotensin (1–7)-Mas Receptor Axis: Fetal Programing, Sex Differences, and Intracellular Pathways

(2014) Mark C. Chappell et al.   Frontiers in Endocrinology

Clinical Perspectives and Fundamental Aspects of Local Cardiovascular and Renal Renin-Angiotensin Systems

(2014) Walmor C. De Mello et al.   Frontiers in Endocrinology

Do intravenous and subcutaneous angiotensin II increase blood pressure by different mechanisms?

(2013) Duncan J Campbell   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Effect of Aliskiren on Postdischarge Mortality and Heart Failure Readmissions Among Patients Hospitalized for Heart Failure

(2013) Mihai Gheorghiade et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The absence of intrarenal ACE protects against hypertension

(2013) Romer A. Gonzalez-Villalobos et al.   JOURNAL OF CLINICAL INVESTIGATION

A Role for the Brain RAS in Alzheimer’s and Parkinson’s Diseases

(2013) John W. Wright et al.   Frontiers in Endocrinology

Contribution of the Local RAS to Hematopoietic Function: A Novel Therapeutic Target

(2013) Kathleen E. Rodgers et al.   Frontiers in Endocrinology

Autophagy and the (Pro)renin Receptor

(2013) Katrina J. Binger et al.   Frontiers in Endocrinology

The Role of Tissue Renin-Angiotensin-Aldosterone System in the Development of Endothelial Dysfunction and Arterial Stiffness

(2013) Annayya R. Aroor et al.   Frontiers in Endocrinology

Local Renin-Angiotensin System in the Reproductive System

(2013) Daniel Herr et al.   Frontiers in Endocrinology

New Frontiers in the Intrarenal Renin-Angiotensin System: A Critical Review of Classical and New Paradigms

(2013) Jia L. Zhuo et al.   Frontiers in Endocrinology

Pregnancy Outcome Following Exposure to Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Antagonists

(2012) Marina Bullo et al.   HYPERTENSION

Liver Angiotensinogen Is the Primary Source of Renal Angiotensin II

(2012) T. Matsusaka et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Angiotensin II generation in vivo: does it involve enzymes other than renin and angiotensin-converting enzyme?

(2012) Duncan J Campbell   JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM

Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes

(2012) Hans-Henrik Parving et al.   NEW ENGLAND JOURNAL OF MEDICINE

Aliskiren increases bradykinin and tissue kallikrein mRNA levels in the heart

(2011) Duncan J Campbell et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunction

(2011) Scott D. Solomon et al.   EUROPEAN HEART JOURNAL

Spectrum of mutations in the renin-angiotensin system genes in autosomal recessive renal tubular dysgenesis

(2011) Olivier Gribouval et al.   HUMAN MUTATION

Creation and Characterization of a Renin Knockout Rat

(2011) Carol Moreno et al.   HYPERTENSION

GENETIC MODELS PROVIDE UNIQUE INSIGHT INTO ANGIOTENSIN AND BRADYKININ PEPTIDES IN THE EXTRAVASCULAR COMPARTMENT OF THE HEARTIN VIVO

(2009) Duncan J Campbell et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

(2008) Johannes FE Mann et al.   LANCET

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

(2008)   NEW ENGLAND JOURNAL OF MEDICINE